205 related articles for article (PubMed ID: 22388630)
21. Candidates for peptide receptor radiotherapy today and in the future.
Reubi JC; Mäcke HR; Krenning EP
J Nucl Med; 2005 Jan; 46 Suppl 1():67S-75S. PubMed ID: 15653654
[TBL] [Abstract][Full Text] [Related]
22. GLP-1 and exendin-4 for imaging endocrine pancreas. A review. Labelled glucagon-like peptide-1 analogues: past, present and future.
Hubalewska-Dydejczyk A; Sowa-Staszczak A; Tomaszuk M; Stefańska A
Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):152-60. PubMed ID: 25719487
[TBL] [Abstract][Full Text] [Related]
23. Peptides for tumour therapy and diagnosis: current status and future directions.
Zaccaro L; Del Gatto A; Pedone C; Saviano M
Curr Med Chem; 2009; 16(7):780-95. PubMed ID: 19275595
[TBL] [Abstract][Full Text] [Related]
24. Radiolabelled peptides--promises and pitfalls.
Mather SJ
Nucl Med Commun; 2000 Jun; 21(6):507-9. PubMed ID: 10894558
[No Abstract] [Full Text] [Related]
25. Diagnostic applications of radiolabeled peptides in nuclear endocrinology.
Behr TM; Béhé M; Becker W
Q J Nucl Med; 1999 Sep; 43(3):268-80. PubMed ID: 10568142
[TBL] [Abstract][Full Text] [Related]
26. Radiolabelled peptides for tumour therapy: current status and future directions. Plenary lecture at the EANM 2002.
de Jong M; Kwekkeboom D; Valkema R; Krenning EP
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):463-9. PubMed ID: 12569416
[TBL] [Abstract][Full Text] [Related]
27. Non-oncologic applications of radiolabeled peptides in nuclear medicine.
Knight LC
Q J Nucl Med; 2003 Dec; 47(4):279-91. PubMed ID: 14973420
[TBL] [Abstract][Full Text] [Related]
28. Gene transfer strategies for improving radiolabeled peptide imaging and therapy.
Rogers BE; Zinn KR; Buchsbaum DJ
Q J Nucl Med; 2000 Sep; 44(3):208-23. PubMed ID: 11105586
[TBL] [Abstract][Full Text] [Related]
29. New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology.
Tornesello AL; Buonaguro L; Tornesello ML; Buonaguro FM
Molecules; 2017 Aug; 22(8):. PubMed ID: 28767081
[TBL] [Abstract][Full Text] [Related]
30. An overview of the diagnostic and therapeutic use of monoclonal antibodies in medicine.
Goldsmith SJ; Signore A
Q J Nucl Med Mol Imaging; 2010 Dec; 54(6):574-81. PubMed ID: 21221066
[TBL] [Abstract][Full Text] [Related]
31. Two technetium-99m-labeled cholecystokinin-8 (CCK8) peptides for scintigraphic imaging of CCK receptors.
Laverman P; Béhé M; Oyen WJ; Willems PH; Corstens FH; Behr TM; Boerman OC
Bioconjug Chem; 2004; 15(3):561-8. PubMed ID: 15149184
[TBL] [Abstract][Full Text] [Related]
32. Receptor-mediated tumor targeting with radiolabeled peptides: there is more to it than somatostatin analogs.
Mariani G; Erba PA; Signore A
J Nucl Med; 2006 Dec; 47(12):1904-7. PubMed ID: 17138731
[No Abstract] [Full Text] [Related]
33. Radiopeptide imaging and therapy in the United States.
Graham MM; Menda Y
J Nucl Med; 2011 Dec; 52 Suppl 2():56S-63S. PubMed ID: 22144556
[TBL] [Abstract][Full Text] [Related]
34. Radiolabeled peptides: current and new perspectives.
Opalinska M; Hubalewska-Dydejczyk A; Sowa-Staszczak A
Q J Nucl Med Mol Imaging; 2017 Jun; 61(2):153-167. PubMed ID: 28347132
[TBL] [Abstract][Full Text] [Related]
35. Radiolabelled regulatory peptides for imaging and therapy.
Breeman WA; Kwekkeboom DJ; de Blois E; de Jong M; Visser TJ; Krenning EP
Anticancer Agents Med Chem; 2007 May; 7(3):345-57. PubMed ID: 17504160
[TBL] [Abstract][Full Text] [Related]
36. Peptide-based probes for cancer imaging.
Reubi JC; Maecke HR
J Nucl Med; 2008 Nov; 49(11):1735-8. PubMed ID: 18927341
[TBL] [Abstract][Full Text] [Related]
37. Radiopharmaceuticals for scintigraphic imaging of infection and inflammation.
Boerman OC; Dams ET; Oyen WJ; Corstens FH; Storm G
Inflamm Res; 2001 Feb; 50(2):55-64. PubMed ID: 11289655
[TBL] [Abstract][Full Text] [Related]
38. Peptide-based radiopharmaceuticals: future tools for diagnostic imaging of cancers and other diseases.
Okarvi SM
Med Res Rev; 2004 May; 24(3):357-97. PubMed ID: 14994368
[TBL] [Abstract][Full Text] [Related]
39. Preclinical and clinical studies of peptide receptor radionuclide therapy.
Pool SE; Krenning EP; Koning GA; van Eijck CH; Teunissen JJ; Kam B; Valkema R; Kwekkeboom DJ; de Jong M
Semin Nucl Med; 2010 May; 40(3):209-18. PubMed ID: 20350630
[TBL] [Abstract][Full Text] [Related]
40. Targeted tumor diagnosis and therapy with peptide hormones as radiopharmaceuticals.
Khan IU; Beck-Sickinger AG
Anticancer Agents Med Chem; 2008 Feb; 8(2):186-99. PubMed ID: 18288921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
